Ascendis, Specialised Therapies in pact on endocrinology therapies

 

• Agreement between Ascendis Pharma A/S and ST is for the exclusive distribution and commercialisation of three Ascendis Pharma endocrinology therapies
• Two of the therapies are already internationally approved, the third is in development following successful Phase 2 data
• ST's exclusive distribution agreement covers Australia, New Zealand, Singapore, Malaysia, Brunei, Thailand and Vietnam

https://www.prnewswire.com/news-releases/specialised-therapeutics-signs-exclusive-agreement-with-ascendis-pharma-as-for-distribution-and-commercialisation-of-three-endocrinology-therapies-in-australia-and-select-south-east-asia-countries-302027751.html